Skip to main content
. 2022 Dec 31;11(1):105. doi: 10.3390/microorganisms11010105

Table 4.

Nested case-control study for women with postpartum sepsis.

Cases
(N = 150)
Controls (N = 297) Crude OR Adjusted OR
N % N % OR 95% CI aOR 95% CI
Maternal age (years) <35 103 68.7 167 56.2 1.00 1.00
≥35 47 31.3 103 34.7 0.58 0.38 0.88 0.80 0.42 1.54
Citizenship a Italian 96 64.0 223 75.1 1.00 1.00
Foreign 52 34.7 72 24.2 1.72 1.11 2.68 1.39 0.67 2.88
Education a Low 40 26.7 68 22.9 1.19 0.73 1.94 1.16 0.51 2.64
High 101 67.3 199 67.0 1.00 1.00
Parity Nulliparas 88 58.7 132 44.4 1.80 1.21 2.69 1.76 0.94 3.26
Multiparas 62 41.3 165 55.6 1.00 1.00
BMI a <18.5 9 6.0 18 6.1 1.00 0.42 2.43 1.24 0.34 4.57
18.5–24.9 82 54.7 165 55.6 1.00 1.00
25–29.9 32 21.3 61 20.5 1.05 0.64 1.73 1.26 0.57 2.79
≥30 19 12.7 32 10.8 1.16 0.63 2.15 0.78 0.27 2.23
History of STIs a No 289 192.7 142 47.8 1.00 1.00
Yes 7 4.7 8 2.7 2.46 0.84 7.17 2.70 0.50 14.44
Prior recurrent infections a No 122 81.3 274 92.3 1.00 1.00
Yes 19 12.7 15 5.1 3.08 1.46 6.47 2.68 0.99 7.27
Pregestational medical conditions No 89 59.3 226 76.1 1.00 1.00
Yes 61 40.7 71 23.9 2.22 1.44 3.43 1.93 1.00 3.69
Medical and obstetric history-associated risk factors
Amniocentesis No 144 96.0 292 98.3 1.00 1.00
Yes 6 4.0 5 1.7 2.51 0.69 9.09 3.43 0.59 19.83
PROM No 129 86.0 282 94.9 1.00 1.00
Yes 21 14.0 15 5.1 3.18 1.55 6.51 3.08 0.99 9.53
Complications in current pregnancy b No 105 70.0 260 87.5 1.00 1.00
Yes 45 30.0 37 12.5 3.52 2.02 6.12 1.93 0.80 4.64
Childbirth complications No 128 85.3 283 95.3 1.00 1.00
Yes 22 14.7 14 4.7 3.87 1.81 8.25 1.59 0.50 5.07
PPH > 500 mL No 117 78.0 265 89.2 1.00 1.00
Yes 33 22.0 32 10.8 2.40 1.38 4.18 2.04 0.89 4.69
Vascular catheters No 76 50.7 235 79.1 1.00 1.00
Yes 74 49.3 62 20.9 40.84 9.89 168.61 9.02 1.53 53.09
Intermittent bladder catheterization No 138 92.0 291 98.0 1.00 1.00
Yes 12 8.0 6 2.0 10.00 2.19 45.64 5.22 0.56 48.90
Indwelling bladder catheterization No 76 50.7 237 79.8 1.00 1.00
Yes 74 49.3 60 20.2 41.84 10.14 172.6 9.86 2.00 48.62
>5 vaginal explorations a No 109 72.7 229 77.1 1.00 1.00
Yes 33 22.0 35 11.8 2.16 1.20 3.88 1.78 0.79 4.00

a Percentages and odds-ratios calculated including “unknown information” in the analysis. b Gestational complications (% in cases and controls): anemia (10.9–3.3%); severe infection (2.7–0.3%); respiratory distress syndrome prophylaxis (11.4–4.4%); threatening preterm labor (7.1–3.6%); vagino-rectal swab and/or urine culture positive for GBS (7.6–3.1%). STIs, sexually transmitted infections: HIV, syphilis, N. gonorrhea, C. trachomatis, genital herpes, hepatitis B, and hepatitis C. Prior recurrent infections: recurrent otitis, skin infections, cystitis, pyelonephritis, vaginal infections. Pregestational medical conditions: cardiac disease, diabetes, endocrine disorders, mental health disorder/psychiatric disease, anemia or other hematological conditions, inflammatory bowel diseases, renal disease, autoimmune conditions, cancer. Complications in current pregnancy: amniotic fluid embolism, hypertensive disorders of pregnancy, gestational diabetes, hyperemesis gravidarum requiring hospital admission, ovarian hyperstimulation syndrome, small or large for gestational age neonate, placenta previa, placenta abruptio, postpartum hemorrhage requiring blood transfusion, preterm delivery, thromboembolic event, infection requiring hospital admission, stillbirth, surgery in pregnancy, neonatal death. Childbirth complications: hysterectomy, allergic reactions/anaphylaxis, anesthesiology complications. BMI, Body Mass Index; PROM, premature rupture of membranes; PPH, postpartum hemorrhage.